What Is GHK-Cu Topical Serum?
GHK-Cu (glycyl-L-histidyl-L-lysine copper) topical serum is a ready-to-use formulation of the most extensively researched copper peptide in scientific literature. Unlike lyophilized GHK-Cu powder that requires reconstitution with bacteriostatic water, a topical serum is pre-formulated at a specific concentration for direct skin application — no syringes, no mixing, no preparation.
GHK-Cu was first identified in human blood plasma in 1973 by Dr. Loren Pickart. Over 50 years of published research have documented its effects on collagen synthesis, wound healing, gene expression, and skin regeneration. It remains the only peptide demonstrated to influence approximately 4,000 human genes (~6% of the genome) in Broad Institute Connectivity Map analysis. For a full overview of GHK-Cu’s mechanisms, see our GHK-Cu Copper Peptide Research Guide.
Why Topical GHK-Cu?
The majority of GHK-Cu research has used either injectable (subcutaneous) or topical administration. For skin-specific applications, topical delivery offers several advantages:
Direct delivery to target tissue
Topical application concentrates GHK-Cu at the skin level — the exact tissue where its collagen-stimulating, anti-inflammatory, and wound-healing effects are most relevant. Published clinical studies have confirmed that GHK-Cu penetrates the stratum corneum (the outer skin barrier) in bioactive quantities, reaching the dermal layer where collagen synthesis and extracellular matrix remodeling occur.
No reconstitution required
Lyophilized peptide powders require careful reconstitution with bacteriostatic water, sterile syringes, and proper technique. A topical serum eliminates this process entirely — open, apply, done. This makes GHK-Cu accessible to researchers and practitioners who want to evaluate its skin effects without injectable administration infrastructure.
Non-invasive application
For skin research protocols, topical application avoids the variables introduced by injection — no injection site reactions, no systemic distribution diluting the local concentration, and no need for injection technique training.
Published clinical validation
Unlike many peptides that have only injectable research data, GHK-Cu has been tested topically in human clinical trials. The landmark Abdulghani et al. study used topical GHK-Cu cream and demonstrated that it outperformed both vitamin C and retinoic acid (tretinoin) in measured collagen increases over 12 weeks. This is one of the few peptides with direct clinical evidence supporting topical efficacy.
What the Research Shows
Collagen synthesis
GHK-Cu stimulates collagen production through multiple pathways. In vitro studies have demonstrated up to 70% increases in collagen synthesis. The 12-week clinical trial by Abdulghani et al. showed significant improvements in skin firmness, density, and wrinkle reduction with topical GHK-Cu application — results that exceeded the gold standard comparators (vitamin C and tretinoin).
Skin thickness and elasticity
Clinical studies measuring skin biophysical properties have documented increased dermal thickness, improved elasticity, and reduced skin laxity following topical GHK-Cu application. These changes reflect increased collagen and elastin content in the dermal layer — structural improvements rather than superficial hydration effects.
Wound healing and skin repair
GHK-Cu promotes angiogenesis (new blood vessel formation) through VEGF upregulation, accelerating nutrient delivery to healing tissue. Published animal studies have shown that topical GHK-Cu formulations accelerate wound closure, reduce scarring, and improve the quality of healed tissue. Arul et al. (2007) demonstrated significant wound healing acceleration with topical GHK-Cu application in dermal wound models.
Anti-inflammatory effects
Chronic low-grade skin inflammation contributes to premature aging, hyperpigmentation, and barrier dysfunction. GHK-Cu suppresses pro-inflammatory cytokines including TNF-α, IL-6, and TGF-β while modulating NF-κB signaling — reducing oxidative damage and inflammatory cascades at the skin level.
Antioxidant defense
The copper cofactor in GHK-Cu supports superoxide dismutase (SOD), one of the body’s primary antioxidant enzymes. SOD neutralizes superoxide radicals that damage skin cells, break down collagen, and accelerate photoaging. This copper-dependent antioxidant pathway is unique to GHK-Cu among cosmetic peptides.
Gene expression modulation
Broad Institute Connectivity Map analysis revealed that GHK-Cu modulates approximately 4,000 genes — activating genes associated with tissue repair, stem cell function, and extracellular matrix production while suppressing genes linked to tissue degradation, inflammation, and fibrosis. No other cosmetic peptide has demonstrated this breadth of gene-level activity.
GHK-Cu Topical Serum vs Other Skincare Peptides
| Peptide | Primary Mechanism | Genes Influenced | Human Clinical Data? |
|---|---|---|---|
| GHK-Cu | Collagen synthesis, ECM remodeling, antioxidant, anti-inflammatory | ~4,000 | Yes — outperformed vitamin C and tretinoin |
| Matrixyl (Palmitoyl pentapeptide-4) | Collagen stimulation via TGF-β | Limited data | Yes — wrinkle reduction studies |
| Argireline (Acetyl hexapeptide-3) | SNARE complex inhibition (muscle relaxation) | Minimal | Limited |
| EGF (Epidermal Growth Factor) | Cell proliferation via EGFR | Moderate | Yes — wound healing |
GHK-Cu’s advantage over other cosmetic peptides is its breadth — it simultaneously addresses collagen production, inflammation, oxidative damage, and gene expression across thousands of targets. Most cosmetic peptides operate through a single mechanism.
How to Use GHK-Cu Topical Serum
- Cleanse — wash the target area with a gentle cleanser and pat dry
- Apply — dispense a thin layer of serum onto the skin
- Absorb — allow 2-3 minutes for full absorption before applying moisturizer or sunscreen
- Frequency — apply once or twice daily for consistent research protocols
- Duration — published clinical studies used 12-week protocols to demonstrate measurable results
Note: A light blue tint on the skin immediately after application is normal and characteristic of the copper peptide complex. It absorbs fully within minutes.
PSPeptides GHK-Cu Topical Serum
PSPeptides Copper Peptide GHK-Cu Topical Serum is a 1% concentration formula in a 3mL bottle — matching the concentration range used in published clinical research. US manufactured with 99%+ purity verified via independent HPLC and mass spectrometry.
- Concentration: 1% GHK-Cu
- Volume: 3mL (~60 applications)
- Price: $32.99
- Format: Ready-to-use (no reconstitution required)
PSPeptides also offers lyophilized GHK-Cu vials (50mg and 100mg) for researchers requiring injectable administration, and two multi-peptide blends containing GHK-Cu:
- GLOW Blend — BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg) — $79.99
- KLOW Blend — BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg) + KPV (10mg) — $129.99
Frequently Asked Questions
What concentration of GHK-Cu is effective topically?
Published clinical studies have used topical GHK-Cu at concentrations of 1-4%. The PSPeptides serum is formulated at 1% — within the clinically validated range. Higher concentrations are not necessarily more effective, as GHK-Cu operates through receptor-mediated signaling rather than dose-dependent saturation.
Can I use GHK-Cu serum with other skincare products?
GHK-Cu is compatible with most skincare ingredients. Apply the serum first on clean skin, allow 2-3 minutes to absorb, then layer moisturizers or sunscreen over it. Avoid combining with strong acids (AHA/BHA at high concentrations) in the same application, as extreme pH can destabilize the copper-peptide complex.
How quickly will I see results?
Published clinical data shows measurable changes in collagen density and skin firmness at 12 weeks of consistent use. Some researchers report visible improvements in skin texture and hydration within 4-6 weeks. Like all peptide-based skincare, consistency over time produces the most significant outcomes.
Is the blue tint permanent?
No. The light blue tint from the copper complex absorbs fully into the skin within 2-3 minutes of application. It does not stain or discolor the skin.
How is this different from injectable GHK-Cu?
The topical serum delivers GHK-Cu directly to the skin surface and dermal layer — ideal for localized skin research. Injectable (subcutaneous) GHK-Cu distributes systemically through the bloodstream, reaching skin from the inside. Both routes have published evidence of efficacy. Topical is simpler to use; injectable provides systemic effects beyond skin.
References
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
- Abdulghani AA, et al. Effects of topical creams containing vitamin C, a copper-binding peptide cream and melatonin compared with tretinoin. Disease Management and Clinical Outcomes. 1998;1(4):136-141.
- Arul V, et al. Wound healing effect of topical application of GHK-Cu on dermal wound models. Life Sci. 2007;80(14-15):1351-1355.
Buy GHK-Cu Topical Serum — $32.99 →
This content is for educational and research purposes only.
PSPeptides — US Made & Shipped | Third-Party Tested | 99%+ Purity | Same-Day Shipping